MODULATION OF OPIOID AND NMDA RECEPTOR MRNA BY RIBOZYMES
MODULATION OF OPIOID AND NMDA RECEPTOR MRNA BY RIBOZYMES
批准号:
2414623
负责人:
HUGH D ROBERTSON
金额:
$13.27万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-06-01 至 1999-04-30
中文摘要
我们建议进行旨在适应核酶方法的研究
英文摘要
We propose to conduct research designed to adapt the ribozyme approach to
provide a transient or permanent "knockout" of a target protein (and its
associated function) by cleaving the appropriate mRNA with high
specificity. This approach is one which is already showing promise in the
antiviral field, where a number of advantages for it have emerged. RNA-
level approaches in general are succeeding in antiviral therapy for
hepatitis B virus, for example; the ribozyme approach is most promising
because one ribozyme can attack a number of RNAs because of its
catalytic/enzymatic properties. The other major approach-antisense
inhibition--works at a 1:1 level. We propose to adapt approaches which are
showing promise in the antiviral field to key cellular RNAs, including
mRNAs for mouse delta opioid receptors (DORs) and glutamate receptor
channel subunits (NMDAs) in test tube experiments using cloned mRNA
expression vectors; and in cultured mouse nerve cells, specifically the
NGl08-l5 cell line.
We plan to test the hypothesis that the ribozyme technique, using either
delta hepatitis agent ribozymes retargeted to the relevant mRNAs; or
external guide sequences (EGSs) which re-target the cellular tRNA
processing enzyme RNase P to exogenous sequences, can provide a transient
"knockout" of a targeted mRNA, and its associated functional protein. The
cellular approach is the logical endpoint of the initial research effort,
with work in animals to follow. The collaborative efforts of the Robertson
Lab (RNA structure/function; ribozyme development) and the Inturrisi Lab
(mRNA and cell characterization; RNA detection) have already led to
several publications in the field of RNA quantitation. We will collaborate
on testing the above mRNAs, comparing the ribozyme approaches mentioned to
parallel efforts using antisense deoxyribonucleotides. In this way we
should be able to introduce these approaches into the field of drug abuse
research, where they should allow an increase in systematic studies of the
effects of expression involving various receptor genes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HCV INTERNAL RIBOSOME ENTRY SITE AS TARGET FOR THERAPY
-
批准号:2906461
-
项目类别:
-
资助金额:$29.82万
-
财政年份:1999
-
负责人:HUGH D ROBERTSON
-
依托单位:
HCV INTERNAL RIBOSOME ENTRY SITE AS TARGET FOR THERAPY
-
批准号:6381649
-
项目类别:
-
资助金额:$31.63万
-
财政年份:1999
-
负责人:HUGH D ROBERTSON
-
依托单位:
HCV INTERNAL RIBOSOME ENTRY SITE AS TARGET FOR THERAPY
-
批准号:6524545
-
项目类别:
-
资助金额:$32.58万
-
财政年份:1999
-
负责人:HUGH D ROBERTSON
-
依托单位:
HCV INTERNAL RIBOSOME ENTRY SITE AS TARGET FOR THERAPY
-
批准号:6177909
-
项目类别:
-
资助金额:$30.71万
-
财政年份:1999
-
负责人:HUGH D ROBERTSON
-
依托单位:
HCV INTERNAL RIBOSOME ENTRY SITE AS TARGET FOR THERAPY
-
批准号:6630532
-
项目类别:
-
资助金额:$33.56万
-
财政年份:1999
-
负责人:HUGH D ROBERTSON
-
依托单位:
MODULATION OF OPIOID AND NMDA RECEPTOR MRNA BY RIBOZYMES
-
批准号:2700904
-
项目类别:
-
资助金额:$26.09万
-
财政年份:1996
-
负责人:HUGH D ROBERTSON
-
依托单位:
MODULATION OF OPIOID AND NMDA RECEPTOR MRNA BY RIBOZYMES
-
批准号:2544656
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1996
-
负责人:HUGH D ROBERTSON
-
依托单位:
MODULATION OF OPIOID AND NMDA RECEPTOR MRNA BY RIBOZYMES
-
批准号:2123782
-
项目类别:
-
资助金额:$12.75万
-
财政年份:1996
-
负责人:HUGH D ROBERTSON
-
依托单位:
MOLECULAR BIOLOGY OF THE DELTA AGENT
-
批准号:2066065
-
项目类别:
-
资助金额:$27.41万
-
财政年份:1992
-
负责人:HUGH D ROBERTSON
-
依托单位:
MOLECULAR BIOLOGY OF THE DELTA AGENT
-
批准号:3146056
-
项目类别:
-
资助金额:$25.22万
-
财政年份:1992
-
负责人:HUGH D ROBERTSON
-
依托单位:
MOLECULAR BIOLOGY OF THE DELTA AGENT
-
批准号:3146055
-
项目类别:
-
资助金额:$22.45万
-
财政年份:1992
-
负责人:HUGH D ROBERTSON
-
依托单位:
MOLECULAR BIOLOGY OF THE DELTA AGENT
-
批准号:2066066
-
项目类别:
-
资助金额:$29.01万
-
财政年份:1992
-
负责人:HUGH D ROBERTSON
-
依托单位:
MOLECULAR BIOLOGY OF THE DELTA AGENT
-
批准号:2066064
-
项目类别:
-
资助金额:$26.41万
-
财政年份:1992
-
负责人:HUGH D ROBERTSON
-
依托单位:
MOLECULAR BIOLOGY OF THE DELTA AGENTS
-
批准号:2649896
-
项目类别:
-
资助金额:$32.22万
-
财政年份:1992
-
负责人:HUGH D ROBERTSON
-
依托单位:
RNA-LEVEL THERAPEUTICS FOR HEPATITIS B AND DELTA VIRUSES
-
批准号:3547884
-
项目类别:
-
资助金额:$16.74万
-
财政年份:1991
-
负责人:HUGH D ROBERTSON
-
依托单位:
RNA-LEVEL THERAPEUTICS FOR HEPATITIS B AND DELTA VIRUSES
-
批准号:2066827
-
项目类别:
-
资助金额:$18.51万
-
财政年份:1991
-
负责人:HUGH D ROBERTSON
-
依托单位:
RNA-LEVEL THERAPEUTICS FOR HEPATITIS B AND DELTA VIRUSES
-
批准号:3547883
-
项目类别:
-
资助金额:$17.46万
-
财政年份:1991
-
负责人:HUGH D ROBERTSON
-
依托单位:
REGULATORY RNA IN HELA AND OTHER CELLS
-
批准号:3275592
-
项目类别:
-
资助金额:$13.53万
-
财政年份:1988
-
负责人:HUGH D ROBERTSON
-
依托单位:
REGULATORY RNA IN HELA AND OTHER CELLS
-
批准号:3275591
-
项目类别:
-
资助金额:$13.65万
-
财政年份:1988
-
负责人:HUGH D ROBERTSON
-
依托单位:
REGULATORY RNA IN HELA AND OTHER CELLS
-
批准号:3275584
-
项目类别:
-
资助金额:$13.33万
-
财政年份:1980
-
负责人:HUGH D ROBERTSON
-
依托单位: